Trial Filter

BETA

An intelligent search tool for clinical trials

Sign In
Back|NCT06595160Recruiting
Official Title

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma Patients

Sponsor
Emory University
Enrollment
87
Timeline
Aug 2024 → Aug 2027
About This Study

This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal adenocarcinoma.

Eligibility Criteria

Inclusion Criteria

  • 1\* Age ≥ 18 years with signed informed consent form
  • 2Patients must have a histological diagnosis of PDAC
  • 3Resectable or borderline resectable PDAC on imaging

Exclusion Criteria

  • 1\* Patients with locally advanced and metastatic stage IV PDAC
  • 2Patients who have already received or completed neoadjuvant chemotherapy for PDAC
  • 3Patients with active malignancy receiving systemic therapy

Locations

1 site participating in this study

Emory University Hospital/Winship Cancer Institute

Atlanta, Georgia 30322

Recruiting

Mihir M. Shah

Data sourced from ClinicalTrials.govView on ClinicalTrials.gov →